August 29, 2025
Based on the FAQ section in the ACC's 2025 Concise Clinical Guidance on vaccination in adults with CVD, this short slideshow also offers recommended answers.
August 29, 2025
Teva announced approval of the generic formulation of Saxenda, which could help expand access to the extremely popular class of antiobesity medications.
August 28, 2025
Teresa Lovins, MD, highlights a study that showed a 14% increase in rates of safety planning within 2 weeks of a negative screening led to a 25% decrease in attempted suicides.
August 28, 2025
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
August 28, 2025
In a trial of over 112 000 US adults, researchers found that 14% started a GLP-1 receptor agonist after bariatric surgery.
August 28, 2025
The ACC provides evidence-based guidance on improving vaccine uptake in vulnerable patients, addressing vaccine hesitancy, and improving overall vaccine access.
August 28, 2025
ESC 2025: The first global investigation of evidence for the potential positive connection is encouraging, but more research is needed to understand causality.
August 27, 2025
Infectious disease and family medicine experts share guidance on vaccine policy changes, patient communication, and boosting vaccine confidence.
August 27, 2025
Teresa Lovins, MD, sees at least 1 or 2 patients a week who have suicidal ideation. Too many of them are at risk for an attempt within a month of those visits.
August 27, 2025
MRGPRX2 antagonism is the only known mechanism of action designed to modulate mast cells and sensory neurons, both key drivers of lesions and itch in AD.